The Food and Drug Administration on Monday named a longtime pharmaceutical executive to run the agency’s drug program, the ...

Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is getting better, and use is not mandatory.